These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 32739122)

  • 21. Attempting to remedy sub-optimal medication adherence in haemophilia: The rationale for repeated ultrasound visualisations of the patient's joint status.
    Di Minno A; Spadarella G; Nardone A; Mormile M; Ventre I; Morfini M; Di Minno G
    Blood Rev; 2019 Jan; 33():106-116. PubMed ID: 30146094
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hemophilia Gene Therapy: Ready for Prime Time?
    VandenDriessche T; Chuah MK
    Hum Gene Ther; 2017 Nov; 28(11):1013-1023. PubMed ID: 28793786
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gene Therapy in Hemophilia: Recent Advances.
    Rodríguez-Merchán EC; De Pablo-Moreno JA; Liras A
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299267
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prospects for gene therapy of haemophilia A and B.
    Brownlee GG
    Br Med Bull; 1995 Jan; 51(1):91-105. PubMed ID: 7767651
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The second Team Haemophilia Education Meeting, 2016, Frankfurt, Germany.
    Berntorp E; Dargaud Y; Hart D; Lobet S; Mancuso ME; d'Oiron R; Perry D; Pollard D; van den Berg M; Blatný J; Chambost H; Doria AS; Holme PA; Kaczmarek R; Mantovani L; McLaughlin P; Nanayakkara L; Petrini P; Sannié T; Laane E; Maia R; Dettoraki A; Farrell A; Halimeh S; Raza S; Taylor S
    Eur J Haematol; 2017 Jan; 98 Suppl 85():1-15. PubMed ID: 28101938
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Molecular Revolution in the Treatment of Hemophilia.
    Butterfield JSS; Hege KM; Herzog RW; Kaczmarek R
    Mol Ther; 2020 Apr; 28(4):997-1015. PubMed ID: 31843450
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The changing treatment landscape in haemophilia: from standard half-life clotting factor concentrates to gene editing.
    Mancuso ME; Mahlangu JN; Pipe SW
    Lancet; 2021 Feb; 397(10274):630-640. PubMed ID: 33460559
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A golden age for Haemophilia treatment?
    Makris M; Hermans C
    Haemophilia; 2018 Mar; 24(2):175-176. PubMed ID: 29601683
    [No Abstract]   [Full Text] [Related]  

  • 29. Gene therapy for haemophilia "A" and "B": efficacy, safety and immune consequences.
    Chuah MK; Vandendriessche T
    Bull Mem Acad R Med Belg; 2007; 162(5-6):357-61. PubMed ID: 18405006
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The first Team Haemophilia Education meeting, 2015, Amsterdam, The Netherlands.
    Berntorp E; Hart D; Mancuso ME; d'Oiron R; Perry D; O'Mahony B; Kaczmarek R; Crato M; Pasi J; Miners A; Carlsson KS; Kitchen S; Boehlen F; Giangrande P; Cebura E; Uitslager N; Osooli M; Janeckova D; Haldon R; Rivolta GF
    Eur J Haematol; 2016 Jul; 97 Suppl 83():3-18. PubMed ID: 27272000
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A preliminary application of a haemophilia value framework to emerging therapies in haemophilia.
    Skinner MW; Dolan G; Eichler H; O'Mahony B;
    Haemophilia; 2022 Mar; 28 Suppl 2():9-18. PubMed ID: 35318780
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An exploration of why men with severe haemophilia might not want gene therapy: The exigency study.
    Fletcher S; Jenner K; Holland M; Chaplin S; Khair K
    Haemophilia; 2021 Sep; 27(5):760-768. PubMed ID: 34265145
    [TBL] [Abstract][Full Text] [Related]  

  • 33. What´s new in Gene Therapy of Hemophilia.
    Rodriguez-Merchan EC
    Curr Gene Ther; 2018; 18(2):107-114. PubMed ID: 29446741
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reimbursing the value of gene therapy care in an era of uncertainty.
    Noone D; Coffin D; Pierce GF
    Haemophilia; 2021 Jan; 27(1):12-18. PubMed ID: 33245824
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Viral vector-mediated gene therapy for hemophilia.
    VandenDriessche T; Collen D; Chuah MK
    Curr Gene Ther; 2001 Sep; 1(3):301-15. PubMed ID: 12109144
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel therapeutic approaches for haemophilia.
    Shetty S; Ghosh K
    Haemophilia; 2015 Mar; 21(2):152-161. PubMed ID: 25521966
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gene therapy for hemophilia: Current status and laboratory consequences.
    Batty P; Lillicrap D
    Int J Lab Hematol; 2021 Jul; 43 Suppl 1():117-123. PubMed ID: 34288447
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Implications of haemophilia gene therapy for the changing role of the multidisciplinary team.
    Miesbach W; Barcenilla SG; Golan G; Lobet S
    Haemophilia; 2022 Jan; 28(1):e12-e14. PubMed ID: 34668286
    [No Abstract]   [Full Text] [Related]  

  • 39. Gene therapy ethics and haemophilia: an inevitable therapeutic future?
    Dimichele D; Miller FG; Fins JJ
    Haemophilia; 2003 Mar; 9(2):145-52. PubMed ID: 12614364
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current and future prospects for hemophilia gene therapy.
    Ward P; Walsh CE
    Expert Rev Hematol; 2016 Jul; 9(7):649-59. PubMed ID: 27153210
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.